Asthma Clinical Trials in New York

Showing 81-100 of 229 trials

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

NCT05153408

This is a Phase 1/2, open-label, first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of BLU-701 as monotherapy or in combination with either osimertinib or platinum-based chemotherapy in patients with EGFRm NSCLC.

Lung NeoplasmCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+24 more

Blueprint Medicines Corporation20 participantsStarted Jan 2022

Boston, Massachusetts, United States • Detroit, Michigan, United States • New York, New York, United States +4 more locations

COMPLETEDNA< 1 mile

Symptom Perception

NCT03646669

Older asthmatics have considerably worse outcomes than younger patients with asthma. In this study, the investigators will evaluate the role of symptom perception as a key determinant of poorer outcomes and lower adherence to asthma self-management behaviors among older asthmatics. The proposed study is significant for its potential to greatly advance understanding of the mechanisms related to worse outcomes in older adults, and it will provide actionable data for new interventions to improve self-management.

Asthma

Icahn School of Medicine at Mount Sinai58 participantsStarted Feb 2019

New York, New York, United States • The Bronx, New York, United States • The Bronx, New York, United States

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Symptom Perception

Asthma Trials in Other Cities

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Asthma and Obesity: Pilot Study

Trial of Roflumilast in Asthma Management (TRIM)

Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Evaluation of Negative Inspiratory Flow in Children With Acute Asthma

A Prospective Study Measuring Exhaled Nitric Oxide in Exercise-Induced Asthma

Effectiveness and Safety of Omalizumab in Children With Allergic Asthma.

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Improving Quality by Maintaining Accurate Problems in the EHR

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

Other Conditions in New York